M&A Deal Summary

Discovery Life Sciences Acquires ReachBio Research Labs

On April 11, 2023, Discovery Life Sciences acquired life science company ReachBio Research Labs

Acquisition Highlights
  • This is Discovery Life Sciences’ 7th transaction in the Life Science sector.
  • This is Discovery Life Sciences’ 5th transaction in the United States.
  • This is Discovery Life Sciences’ 1st transaction in Washington.

M&A Deal Summary
Date 2023-04-11
Target ReachBio Research Labs
Sector Life Science
Buyer(s) Discovery Life Sciences
Deal Type Add-on Acquisition

Target

ReachBio Research Labs

Seattle, Washington, United States
ReachBio Research Labs is a company specializing in cell-based assays, predictive hematotoxicity, and drug screening services. The company covers many aspects of primary cell biology, with a special focus on hematopoietic (blood and bone marrow) primary cell systems. Its platform is broad and includes predictive and investigative toxicology, immunology, efficacy testing, cell bank development, biomarker selection, flow cytometry/cell sorting, assay development, and much more. ReachBio Research Labs is based in Seattle, Washington.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Discovery Life Sciences

Huntsville, Alabama, United States
Category Company
Founded 2018
Sector Life Science
DESCRIPTION

Discovery Life Sciences is a provider of biospecimen analysis, procurement, distribution, and genomic, cell-based and histology-based scientific services for the pharmaceutical, biotechnology, and diagnostics industries. HudsonAlpha Discovery is Discovery’s sequencing and bioinformatics division, a globally recognized service laboratory that leverages the most current genomic research technologies to comprehensively support discovery, translational, and clinical research. Discovery Life Sciences was founded in 2018 and is based in Huntsville, Alabama.

DEAL STATS #
Overall 7 of 7
Sector (Life Science) 7 of 7
Type (Add-on Acquisition) 6 of 6
State (Washington) 1 of 1
Country (United States) 5 of 5
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-12 AllCells

Alameda, California, United States

AllCells is a provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products. AllCells was founded in 1998 and is based in Alameda, California.

Buy -
Mergr

Product

Company

Legal